The human immune system is a highly complex network of cells, signals, and responses that is tightly regulated to ensure that the body can fight off infection without damaging its own tissues. Now, ...
Scar-like cells that make up a sizable portion of malignant pancreatic tumors and shield these cancers from immune attack are derived from mesothelial cells that line tissues and organs, a new study ...
68% of patients treated with ELI-002 developed cytotoxic mKRAS-specific CD4+ T cells 84% of patients treated with ELI-002 developed cytotoxic mKRAS-specific CD8+ T cells The majority of ...
The human immune system is a highly complex network of cells, signals, and responses that is tightly regulated to ensure that the body can fight off infection without damaging its own tissues. Now, ...
Phase II trial of patients (pts) with extensive stage small cell lung cancer (ES-SCLC) immunized with p53-transduced dendritic cells (p53-DC): Immune sensitization to chemotherapy (CT) No significant ...
The antigen test uses a novel fluorescent probe for optical detection on the chip. This illustration shows the full antigen-capture complex assembled as a sandwich assay on a magnetic bead; a linker ...
Marengo Therapeutics, Inc., a clinical-stage biotech company, develops novel TCR-targeting antibodies that selectively modulate common and disease-specific T cell subsets of the germline TCR ...
Marker Therapeutics and ABB Robotics designed a robotic assistant prototype intended to be placed in a standard biosafety cabinet to collaborate with a human operator during mTAA-specific T cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results